Granules India Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,470.61 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.96 per cent from ₹1,387.94 crore. This corresponds to a year-on-year *(YoY) growth of 22.81 per cent.
Operating Profit
Operating Profit stands at ₹352.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.28 per cent from ₹308.10 crore. This corresponds to a year-on-year *(YoY) growth of 39.52 per cent.
PBDT
PBDT stands at ₹344.11 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.78 per cent from ₹275.77 crore. This corresponds to a year-on-year *(YoY) growth of 31.82 per cent.
Profit Before Tax
Profit Before Tax stands at ₹262.36 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.73 per cent from ₹202.24 crore. This corresponds to a year-on-year *(YoY) growth of 32.81 per cent.
Net Profit
Net Profit stands at ₹201.57 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.19 per cent from ₹150.21 crore. This represents a 32.59 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Granules India Ltd News
Granules India Ltd Earnings
- YOY
- QOQ
Granules India Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Granules India Ltd Research Reports
Granules India Ltd Financial Reports
Granules India Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Granules India | -0.68% | 1.30% | 6.22% | 41.13% | 45.04% | 47.07% |
| OneSource Speci. | -2.58% | -2.51% | -1.46% | 18.16% | 7.44% | -7.21% |
| Pfizer | 0.68% | -1.16% | -6.20% | -6.65% | -10.30% | -20.52% |
| Rubicon Research | -7.29% | 3.01% | 26.29% | 57.46% | 95.49% | 91.59% |
| ERIS Lifescience | -0.37% | -1.33% | -1.63% | 2.46% | -11.44% | -16.80% |
| Cohance Life | 1.32% | 0.36% | -11.13% | 52.60% | -18.80% | -58.04% |
| Natco Pharma | -2.75% | -4.24% | -22.57% | -10.83% | -0.57% | 3.50% |
Company Info
Company Information
CMD & Executive Director : C Krishna Prasad
Non Independent Executive Director / Joint MD : KANDIRAJU VENKATA SITARAMRAO
ED (Non-Independent) : Uma Devi Chigurupati
ED (Non-Independent) : Harsha Chigurupati
NIED /Head /Promoter : PRIYANKA CHIGURUPATI
Non-Exec & Non-Independent Dir : K B Sankara Rao
Independent Non Exe. Director : Arun Sawhney
Independent Non Exe. Director : Saumen Chakraborty
Independent Non Exe. Director : Sucharita Rao Palepu
Independent Non Exe. Director : Kapil Mehan
Independent Non Exe. Director : S Ravi
Independent Non Exe. Director : Rajiv Kakodkar
Company Sec. & Compli. Officer : Chaitanya Tummala